Scientists say a compound found in honeybee venom showed powerful effects against aggressive breast cancer cells during laboratory testing.

Yes, the claim is based on real scientific research — but with important context.

A 2020 study published in the journal npj Precision Oncology found that melittin, a major component of honeybee venom, was able to rapidly destroy aggressive breast cancer cells in laboratory experiments. Researchers reported that specific concentrations of the venom killed 100% of certain triple-negative and HER2-enriched breast cancer cells within 60 minutes while having minimal impact on normal cells.

Scientists explained that melittin works by damaging cancer cell membranes and interfering with growth signals that help tumors spread. Additional scientific reviews have also confirmed that bee venom and its compounds show promising anticancer effects in experimental studies.

However, experts stress that these findings were mainly from lab and early-stage research. Bee venom is not currently an approved cure for breast cancer, and more human clinical trials are needed before it could become a mainstream treatment.

Disclaimer:

The research was conducted mainly in laboratory settings and does not mean bee venom is a proven or approved cure for breast cancer in humans. Medical treatments should only be followed under professional healthcare guidance.